Mirae Asset Global Investments Co. Ltd. Raises Position in Agilent Technologies, Inc. $A

Posted by Brenda Bartman on Aug 14th, 2026

Mirae Asset Global Investments Co. Ltd. boosted its holdings in Agilent Technologies, Inc. (NYSE:A – Free Report) by 9.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 65,559 shares of the medical research company’s stock after purchasing an additional 5,570 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Agilent Technologies were worth $8,708,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new position in shares of Agilent Technologies in the fourth quarter worth about $549,158,000. AQR Capital Management LLC lifted its stake in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after acquiring an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after acquiring an additional 1,340,161 shares during the period. Balyasny Asset Management L.P. grew its position in Agilent Technologies by 192.0% during the 4th quarter. Balyasny Asset Management L.P. now owns 1,412,535 shares of the medical research company’s stock worth $192,204,000 after acquiring an additional 928,821 shares during the last quarter. Finally, SG Americas Securities LLC grew its position in Agilent Technologies by 107.2% during the 1st quarter. SG Americas Securities LLC now owns 1,674,856 shares of the medical research company’s stock worth $190,900,000 after acquiring an additional 866,641 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities analysts have commented on A shares. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Sunday, August 2nd. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Sanford C. Bernstein began coverage on shares of Agilent Technologies in a report on Friday, June 26th. They set an “outperform” rating and a $155.00 price target for the company. Robert W. Baird increased their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Finally, Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $160.24.

View Our Latest Analysis on A

Agilent Technologies Price Performance

Shares of A stock opened at $149.33 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The firm has a market cap of $42.18 billion, a P/E ratio of 29.99, a P/E/G ratio of 2.62 and a beta of 1.25. The business’s 50 day moving average price is $135.12 and its 200-day moving average price is $125.40.

Agilent Technologies (NYSE:A – Get Free Report) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter in the prior year, the company earned $1.31 earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were issued a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is 20.48%.

Agilent Technologies Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.